ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 3090 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 3090; 2) Community: the network communities that were significantly associated with the response to NSC 3090; 3) Molecule: the relationships between components within communities and NSC 3090; 4) MDR: the compounds that were significantly associated with the NSC 3090.

NSC Compound Enrichment Correlation
NSC 692580 Null 0.0273093708703115 0.43995155
NSC 694000 2-Butenedioic acid, (E)-, 2-[3-[[[[2-(acetyloxy)ethoxy] methyl]-3H-1,2,3-triazol-4-yl]methyl]- 1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-,diethyl ester 0.0273093708703115 0.016279992
NSC 697189 Null 0.0273093708703115 0.11322982
NSC 697886 17-Demethoxy-17-allylamino geldanamycin-11-[4-(dimethylamino)butyrate] 0.0273093708703115 0.23322001
NSC 702734 Null 0.0273093708703115 0.25403816
NSC 706995 Entinostat 0.0273093708703115 0.27150261
NSC 714685 Null 0.0273093708703115 0.13786781
NSC 717065 Null 0.0273093708703115 0.23758461
NSC 717842 Acetamide, 2-[[[2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)- 1,2-dihydro-3H-indol-3-ylidene]amino]oxy]-, (2Z)- 0.0273093708703115 0.15528745
NSC 725670 5,6-Dihydro-5,11-dioxo-6-(2-N-piperazine-1-ethyl)-11H-indeno [1,2-c]isoquinoline 0.0273093708703115 0.39532539
Total:86  Current:53    [First] [Prev] [Next] [Last]